Ruti Aga's Six-Year Ban: The Real Story Is Not a Steroid but a Forged Prescription

Ruti Aga, the 2026 Tokyo Marathon champion, has been banned for six years by the Athletics Integrity Unit. The headline says methylprednisolone, a “prohibited steroid.” The science says otherwise. Methylprednisolone is a glucocorticoid, WADA Prohibited List class S9, prohibited in-competition only by injection, oral or rectal route. That distinction is the legal hinge of the entire case — and the media missed it. The facts are narrow. Aga won a half marathon in China in March. An in-competition sample showed methylprednisolone. She said she had a knee injury. The prescription she produced was written by a family member with no medical registration, using an “old prescription pad” from a clinic that did not exist. The clinic disowned the pad. Three verification failures. The AIU charged presence (two years) and tampering (four years). The arithmetic — two plus four equals six — tells us the panel rejected the no-significant-fault mitigation. Backdating to 10 September is procedural, not a reduction. The performance story is absent. No time, no split, no field strength for the March race. That absence is itself reportable: the wire reduced a win to one line. Aga’s historic record — Tokyo 2026, three World Marathon Majors second places — survives as a record, but its commercial value is gone. At 32, a six-year ban returns her at roughly 38. Ethiopian women’s marathon depth makes that unselectable. The counter-intuitive core: this is not a steroid case. It is a forged-document case. A knee injection is standard sports medicine in distance runners. Given proper records, timing and route, Aga had a legitimate defence. By fabricating the prescription, she destroyed it. The family-member “doctor” is aggravating, not mitigating. The four-year tampering sanction rests partly on an interview, which raises translation and legal-support questions for an appeal. The broader signal is that the AIU’s enforcement frontier is shifting from detection to document verification. East African road-running entourages often lack credentialed team physicians and TUE infrastructure. The Chinese label-race circuit, where appearance fees and testing collide, is now a high-scrutiny zone. A six-year ban for a glucocorticoid with no proven endurance benefit will be cited as rigour by some and disproportion by others. The real question is simpler: how many athletes are one forged prescription away from career death because they never had a real doctor?